Opko Health (OPK) Cost of Revenue (2010 - 2026)

Opko Health (OPK) has reported Cost of Revenue for 17 consecutive years, with $78.4 million the latest figure, recorded in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $78.4 million, down 26.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.0 million (down 26.03% YoY), and the FY2025 annual result was $400.9 million, down 18.94% from the prior year.
• Cost of Revenue was $78.4 million for Q1 2026 at Opko Health, down from $84.4 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $470.7 million in Q4 2023 and troughed at $20.3 million in Q3 2022.
• Average Cost of Revenue over 5 years is $117.4 million, with a median of $104.6 million recorded in 2025.
• The widest YoY moves for Cost of Revenue: up 823.93% in 2022, down 91.61% in 2022.
• Over 5 years, Cost of Revenue stood at $194.8 million in 2022, then soared by 141.66% to $470.7 million in 2023, then slumped by 71.63% to $133.5 million in 2024, then tumbled by 36.76% to $84.4 million in 2025, then slipped by 7.09% to $78.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $78.4 million in Q1 2026, $84.4 million in Q4 2025, and $101.8 million in Q3 2025.